settlement amounts for peritoneal meso - what's the actual range

Your exposure record from the Johns-Manville Cleveland plant is actually about as clean as it gets from an evidentiary standpoint. That company's asbestos liability has been extensively litigated since the 1980s, and their bankruptcy trust, the Manville Personal Injury Settlement Trust, has paid out claims since around 1988. So one piece of your puzzle may already be partially mapped out.

On the range question, you're right that the numbers are all over the place, and there's a reason for that. Settlement values in asbestos cases typically reflect a combination of factors: exposure documentation, disease severity, age at diagnosis, lost wages, and what jurisdiction the case is filed in. Ohio courts and federal courts can produce pretty different outcomes for similar fact patterns. The higher numbers you're seeing often do come from trial verdicts, but some peritoneal cases settle at significant values precisely because peritoneal is aggressive and juries know it.

Peritoneal vs pleural does matter to some attorneys and some defendants, though not always in the way people expect. Peritoneal cases can sometimes demonstrate a more direct causation argument depending on the exposure type, so it's not automatically worth less.

That symptom journal you've been keeping since diagnosis, keep going with it. Document everything, medical appointments, how symptoms affect daily function, all of it. That kind of record has real value in building damages.

But honestly, the range you're asking about is something that can only be answered accurately after someone reviews your full medical records, work history, and identifies all potentially responsible defendants beyond just the trust claim.

Please consult an attorney who handles asbestos litigation specifically for your situation.

Patricia raised something worth addressing directly. Cell type does correlate with compensation in practice, not because there's a written rule, but because epithelioid typically responds better to treatment and that affects how attorneys frame damages projections and future care costs. Sarcomatoid cases sometimes see higher numbers precisely because the prognosis is more severe and juries respond to that. It cuts both ways depending on how the case is structured.

The symptom journal you've been keeping since November... that's genuinely useful in ways people underestimate. I've seen cases where documented functional decline, things like being unable to do specific tasks on specific dates, added real weight during settlement negotiations because it humanizes the economic damages beyond just medical bills.

Peritoneal vs pleural does matter but maybe not the way you'd expect. Peritoneal meso tends to have longer median survival with HIPEC treatment, and some defense attorneys actually try to use that against plaintiffs in settlement talks. A good attorney knows how to counter that framing. Please do talk to someone who handles this specifically before you draw any conclusions from what you're reading online.